Loading...
The Use of an Antimicrobial Device (BIOPATCH)™ in Preventing CRBSIs in Peripheral IV Catheters
Boateng, Gideon Agyenim ; Estampa, Mary Grace
Boateng, Gideon Agyenim
Estampa, Mary Grace
Citations
Altmetric:
Genre
Poster (Research)
Date
2016
Advisor
Committee member
Department
Nursing
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.34944/dspace/9084
Abstract
Starting a peripheral venous catheter is the most common invasive procedure performed in an inpatient hospital setting (Marsh, 2015). PVCs are routinely used to administer intravenous (IV) medications and other essential therapy. Adverse effects of PVCs include infection, infiltration, phlebitis, painful insertion, and dislodgement. It is considered standard of care in most hospitals to replace PVCs after a certain period of time (average 72-96 hours) to prevent bloodstream infections through the puncture site. However, frequent re-siting of a PVC is in itself a risk for infection as every PVC start breaches the protective barrier that the skin is (Marsh 2015). Thus, there are recommendation by the Center for Diseases Control and Prevention and the Infusion Nurses Society that PVCs be changed when clinically indicated, instead of routinely (Helton 2016; Marsh 2015). The other risk is that once the catheter is in place, the puncture site remains a possible point of entry for the skin’s resident flora to gain access to the bloodstream. Using a BIOPATCH™ protective disk (which is impregnated with chlorhexidine gluconate) at the insertion site can reduce the proliferation rate of normal skin flora and prevent catheter-related bloodstream infections, thereby potentially eliminating one of the major reasons for routine catheter replacements. This project uses literature review to summarize studies on this use of a BIOPATCH™ looking for the health, economic, and patient satisfaction impacts.
Description
Citation
Citation to related work
Has part
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu